Medtronic, Inc. (MDT)’s Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011  
11/4/2011 9:15:07 AM

MINNEAPOLIS--(BUSINESS WIRE)--Offering the broadest range of medical technology for the interventional and surgical treatment of cardiovascular disease, Medtronic, Inc. (NYSE: MDT) today highlighted scientific sessions of interest on the program for TCT 2011, which takes place Nov. 7–11 in San Francisco. Transcatheter Cardiovascular Therapeutics (TCT) is the world’s largest educational meeting specializing in interventional cardiovascular medicine.